BR9406575A - Method of fighting acyclovir-resistant herpes simplex viral infections - Google Patents

Method of fighting acyclovir-resistant herpes simplex viral infections

Info

Publication number
BR9406575A
BR9406575A BR9406575A BR9406575A BR9406575A BR 9406575 A BR9406575 A BR 9406575A BR 9406575 A BR9406575 A BR 9406575A BR 9406575 A BR9406575 A BR 9406575A BR 9406575 A BR9406575 A BR 9406575A
Authority
BR
Brazil
Prior art keywords
acyclovir
fighting
herpes simplex
viral infections
simplex viral
Prior art date
Application number
BR9406575A
Other languages
Portuguese (pt)
Inventor
James Gus Chafouleas
Robert Deziel
Original Assignee
Bio Mega Boehringer Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Mega Boehringer Ingelheim filed Critical Bio Mega Boehringer Ingelheim
Publication of BR9406575A publication Critical patent/BR9406575A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9406575A 1993-05-03 1994-04-29 Method of fighting acyclovir-resistant herpes simplex viral infections BR9406575A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002095408A CA2095408A1 (en) 1993-05-03 1993-05-03 Method of combating acyclovir-resistant herpes simplex viral infections
PCT/CA1994/000242 WO1994025046A1 (en) 1993-05-03 1994-04-29 Method of combating acyclovir-resistant herpes simplex viral infections

Publications (1)

Publication Number Publication Date
BR9406575A true BR9406575A (en) 1996-03-19

Family

ID=4151571

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9406575A BR9406575A (en) 1993-05-03 1994-04-29 Method of fighting acyclovir-resistant herpes simplex viral infections

Country Status (13)

Country Link
EP (1) EP0767671A1 (en)
JP (1) JPH08509476A (en)
KR (1) KR960701651A (en)
CN (1) CN1126438A (en)
AU (1) AU683465B2 (en)
BR (1) BR9406575A (en)
CA (1) CA2095408A1 (en)
CZ (1) CZ287795A3 (en)
HU (1) HUT73779A (en)
NO (1) NO954390L (en)
SG (1) SG48806A1 (en)
SK (1) SK132695A3 (en)
WO (1) WO1994025046A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599887B2 (en) 1988-07-07 2003-07-29 Chimerix, Inc. Methods of treating viral infections using antiviral liponucleotides
US5817638A (en) * 1988-07-07 1998-10-06 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US6252060B1 (en) 1988-07-07 2001-06-26 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
CA2139169C (en) * 1994-12-28 2001-05-01 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Antiherpes peptidomimetic compounds
CN109627243B (en) * 2019-01-09 2021-06-29 广西壮族自治区水产科学研究院 Penciclovir-copper complex, synthetic method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2033448C (en) * 1990-12-31 1996-11-26 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Antiherpes compositions and method of use
SG42995A1 (en) * 1992-03-12 1997-10-17 Bio Mega Boehringer Ingelheim Isosteric antiherpes peptide derivatives

Also Published As

Publication number Publication date
JPH08509476A (en) 1996-10-08
NO954390L (en) 1996-01-02
WO1994025046A1 (en) 1994-11-10
AU683465B2 (en) 1997-11-13
EP0767671A1 (en) 1997-04-16
HU9503135D0 (en) 1996-01-29
CA2095408A1 (en) 1994-11-04
CZ287795A3 (en) 1996-06-12
AU6642394A (en) 1994-11-21
SK132695A3 (en) 1996-10-02
KR960701651A (en) 1996-03-28
SG48806A1 (en) 1998-05-18
NO954390D0 (en) 1995-11-02
CN1126438A (en) 1996-07-10
HUT73779A (en) 1996-09-30

Similar Documents

Publication Publication Date Title
AU4772493A (en) Sulfo-derivatives of adenosine
FI953127A0 (en) purine
NO954880D0 (en) Cytidine deaminase
AU5758594A (en) Treatment of viral infections
AU4688696A (en) Drugs to prevent recurrent herpes virus infections
BR9406575A (en) Method of fighting acyclovir-resistant herpes simplex viral infections
EP0526652A4 (en) Method of type-specific detection of herpes simplex virus
NO983402D0 (en) Nukeoside analogues in combination therapy of herpes simplex infections
AU6748090A (en) Use of caffeine in the treatment of herpes simplex virus infections
AU2591692A (en) Method of treating latent herpes viral infections
NO972688D0 (en) Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpes virus infections
GB9419692D0 (en) Treatment of herpes infections
FI953811A0 (en) Transport and shaping of glass sheets
PT850246E (en) NUCLEOSIDIC DERIVATIVES OF PYRIMIDINE
AU3512793A (en) Process for the expression of herpes simplex virus type 1 glycoprotein I and methods of use
AU3395993A (en) Process for the expression of herpes simplex virus type 1 glycoprotein E and methods of use
KR970038387U (en) Rear scaffolding of van
KR970038295U (en) Joint structure of center follower panel and rear follower panel
KR950014092U (en) Front structure of car
AU5554594A (en) Antiviral agents
DK98093D0 (en) HERPES REMEDY
AU9073691A (en) Combinations of vanilloid compounds and nucleoside antiviral compounds for treatment of herpes infections
SI0876146T1 (en) Nucleoside analogs in combination therapy of herpes simplex infections
AU5960894A (en) Treatment of viral infections
BR9203441A (en) SET OF NUMERAL PLATES

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/70 (2006.01), A61K 31/195 (2006.0